NCI-H524 [H524] (ATCC® CRL-5831™) Organism: Homo sapiens, human / Tissue: lung; derived from metastatic site: lymph node / Disease: stage L,carcinoma; variant small cell lung cancer General Information Characteristics Culture Method Specifications History Documentation Print Email Share Share this product Facebook Twitter Google+ Permits and Restrictions View Restrictions Organism Homo sapiens, human Tissue lung; derived from metastatic site: lymph node Product Format frozen Culture Properties suspension Biosafety Level 1 Disease stage L,carcinoma; variant small cell lung cancer Age 63 years Gender male Ethnicity Caucasian Derivation The line was established in November 1982. Clinical Data 63 years Caucasian male The patient received prior chemotherapy and radiation therapy. The patient was a smoker. Complete Growth Medium The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Cryopreservation Culture medium, 95%; DMSO, 5% Culture Conditions Temperature: 37°C STR Profile Amelogenin: XCSF1PO: 12D13S317: 12D16S539: 12D5S818: 12D7S820: 11,12THO1: 8,9.3TPOX: 8,10vWA: 14,17 Name of Depositor AF Gazdar, JD Minna Year of Origin 1982 References NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. Basic Documentation Product Sheet Certificate of Analysis SDS Restrictions The line is available with the following restrictions: 1. This cell line was deposited at the ATCC by Dr. A. Gazdar and Dr. J. Minna and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. 2. Any proposed commercial use of the these cells, or their products must first be negotiated with the University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235. Telephone (214) 699-8056, FAX (214) 688-7233. References NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.